- Home
- TGE vs DTIL Comparison
TGE vs DTIL Comparison
Compare TGE & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGE
- DTIL
- Stock Information
- Founded
- TGE 2023
- DTIL 2006
- Country
- TGE France
- DTIL United States
- Employees
- TGE N/A
- DTIL N/A
- Industry
- TGE Newspapers/Magazines
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- TGE Consumer Discretionary
- DTIL Health Care
- Exchange
- TGE Nasdaq
- DTIL Nasdaq
- Market Cap
- TGE 85.8M
- DTIL 81.4M
- IPO Year
- TGE N/A
- DTIL 2019
- Fundamental
- Price
- TGE $1.35
- DTIL $5.25
- Analyst Decision
- TGE
- DTIL Strong Buy
- Analyst Count
- TGE 0
- DTIL 2
- Target Price
- TGE N/A
- DTIL $47.00
- AVG Volume (30 Days)
- TGE 12.5M
- DTIL 245.6K
- Earning Date
- TGE 10-20-2025
- DTIL 11-03-2025
- Dividend Yield
- TGE N/A
- DTIL N/A
- EPS Growth
- TGE N/A
- DTIL N/A
- EPS
- TGE N/A
- DTIL N/A
- Revenue
- TGE $130,212,000.00
- DTIL $698,000.00
- Revenue This Year
- TGE N/A
- DTIL N/A
- Revenue Next Year
- TGE N/A
- DTIL $135.19
- P/E Ratio
- TGE $3.33
- DTIL N/A
- Revenue Growth
- TGE 81.03
- DTIL N/A
- 52 Week Low
- TGE $0.78
- DTIL $3.61
- 52 Week High
- TGE $37.02
- DTIL $8.82
- Technical
- Relative Strength Index (RSI)
- TGE N/A
- DTIL 33.72
- Support Level
- TGE N/A
- DTIL $5.67
- Resistance Level
- TGE N/A
- DTIL $6.46
- Average True Range (ATR)
- TGE 0.00
- DTIL 0.59
- MACD
- TGE 0.00
- DTIL -0.27
- Stochastic Oscillator
- TGE 0.00
- DTIL 4.04
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.